Skip to main content
Equibles

Rebecca Frey

CEO

Yarrow Bioscience, Inc. (YARW)

Board Member

Yarrow Bioscience, Inc. (YARW)

Equibles does not estimate personal net worth.

Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get YARW alerts

About Rebecca Frey

Rebecca Frey is recorded as CEO and Board Member at Yarrow Bioscience, Inc. (YARW) since July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Rebecca Frey was appointed Class I director, effective July 27, 2026. Yarrow Bioscience, Inc. reported in an 8-K filed July 28, 2026 that Rebecca Frey was appointed Chief Executive Officer, effective July 27, 2026. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO), Ilan Hadar (CFO) and 7 others.

“On July 27, 2026, the Board set its size at six members and appointed the following six individuals to the Board: Rebecca Frey, Mona Ashiya, Steven Hoerter, Bill Lundberg, Peter Silverman and William White.”
Yarrow Bioscience, Inc. Form 8-K, filed July 28, 2026 · Read the filing
“On July 27, 2026, the Board appointed Rebecca Frey, Pharm.D. as the Company's Chief Executive Officer”
Yarrow Bioscience, Inc. Form 8-K, filed July 28, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Yarrow Bioscience, Inc.

Recent activity